The Cyclotron Radiochemistry Laboratory supports the overall mission of the Center for Quantitative Cancer Imaging by providing cGMP quality positron emission tomography (PET) radiopharmaceuticals for both research and clinical needs. The laboratory was established in November 2002 and has steadily grown in capacity. The main focus of the lab is the production of 18F-Fludeoxyglucose (FDG) for PET imaging, which is distributed to not only Huntsman Cancer Hospital’s clinical needs but the intermountain area as well. The following radiopharmaceuticals and resources are available within the radiochemistry area.


Contact Us

Center for Quantitative Cancer Imaging Director
John M. Hoffman, MD


HCI Senior Director Oversight
Cornelia Ulrich, MS, PhD

Faculty Advisory Committee Chair
David Goldgar, PhD

Faculty Advisory Committee Members
Lisa Aspinwall, PhD
Saundra Buys, MD
Matthew Firpo, PhD
Kimberly Kaphingst, PhD
Deborah Neklason, PhD
Erin Rothwell, MS, PhD
Joshua Schiffman, MD
Theresa Werner, MD